Tadeusz Frankiewicz
About
In The Last Decade
Tadeusz Frankiewicz
11 papers receiving 545 citations
Peers
Comparison fields: 5 of 58
- Cellular and Molecular Neuroscience 425
- Molecular Biology 209
- Physiology 164
- Pharmacology 125
- Cognitive Neuroscience 120
Countries citing papers authored by Tadeusz Frankiewicz
This map shows the geographic impact of Tadeusz Frankiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadeusz Frankiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadeusz Frankiewicz more than expected).
Fields of papers citing papers by Tadeusz Frankiewicz
This network shows the impact of papers produced by Tadeusz Frankiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadeusz Frankiewicz. The network helps show where Tadeusz Frankiewicz may publish in the future.
Co-authorship network of co-authors of Tadeusz Frankiewicz
This figure shows the co-authorship network connecting the top 25 collaborators of Tadeusz Frankiewicz. A scholar is included among the top collaborators of Tadeusz Frankiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadeusz Frankiewicz. Tadeusz Frankiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Vitamin D supplementation – is it only osteoprotection? | 4 |
| 2 | 5 | |
| 3 | 26 | |
| 4 | 29 | |
| 5 | 94 | |
| 6 | 113 | |
| 7 | 98 | |
| 8 | 88 | |
| 9 | 120 | |
| 10 | 2 | |
| 11 | Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.